"Sentara CarePlex Hospital is a technologically advanced, acute care hospital, and Certified Primary Stroke Center located in Hampton, VA. The 224-bed hospital offers an eICU to monitor patients even more closely with state-of-the-art equipment and computer software. Sentara CarePlex Hospital provides care through advanced surgical programs, emergency cardiac intervention, fellowship-trained physicians, and the newly-opened Family Maternity Center . It is also home to the Orthopaedic Hospital at Sentara CarePlex Hospital , the area's first dedicated orthopedic hospital, taking specialized orthopedic care to a new level."

During the past decade, Sentara Cancer Institute at Sentara CarePlex Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 7 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sentara Cancer Institute at Sentara CarePlex Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 7 trials, followed by "Radiation Therapy Oncology Group" with 6 trials sponsored, "National Cancer Institute (NCI)" with 4 trials sponsored, "NRG Oncology" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sentara Cancer Institute at Sentara CarePlex Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "American College of Radiology Imaging Network" with 1 trials as a collaborator and "Astellas Pharma Inc" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Sentara Cancer Institute at Sentara CarePlex Hospital" are "Prostate Cancer" (4 trials), "Stage II Breast Cancer" (4 trials), "Breast Cancer" (2 trials), "Head and Neck Cancer" (2 trials) and "Stage IB Breast Cancer" (2 trials). Many other conditions were trialed in "Sentara Cancer Institute at Sentara CarePlex Hospital" in a lesser frequency.

Most popular intervention types in "Sentara Cancer Institute at Sentara CarePlex Hospital" are "Radiation" (15 trials), "Drug" (12 trials), "Procedure" (8 trials), "Other" (6 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Intensity-Modulated Radiation Therapy" (4 trials), "intensity-modulated radiation therapy" (3 trials), "Capecitabine" (2 trials), "Fluorouracil" (2 trials) and "Laboratory Biomarker Analysis" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sentara Cancer Institute at Sentara CarePlex Hospital" are 12 trials for "All" genders, 5 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Sentara Cancer Institute at Sentara CarePlex Hospital". undefined are not yet recruiting, 2 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Sentara Cancer Institute at Sentara CarePlex Hospital, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sentara Cancer Institute at Sentara CarePlex Hospital, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".